Navigation Links
Chemring Detection Systems Awarded $9M for Biological Detection Systems

CHARLOTTE, N.C., March 14, 2012 /PRNewswire/ -- Chemring Detection Systems ("CDS") a Chemring Group ("Chemring") company, announced a $9M contract award to supply biological detection systems to the Japanese Ministry of Defense. The award was made by Marubeni Aerospace Corporation. The systems will be installed in the Japanese Ground Self Defense Force (JGSDF) NBC Reconnaissance Vehicle.

The system is a variant of the US DOD Joint Biological Point Detection System (JBPDS) and was approved for export by the US State Department. The Joint Biological Point Detection System (JBPDS) provides automatic detection and identification of airborne biological agents at very low levels, triggers local and remote warning systems, and communicates threat information over standard communication systems.  JBPDS is manufactured in CDS' Charlotte, NC facility.

Bill Gural, President of CDS, commented: "We have provided JBPDS to Japan for the last five years in support of achieving their Full Rate Production authorization. This sale demonstrates the relevance of CDS products in the global threat detection market and we are honored to supply a solution for the JGSDF."   

Forty to sixty systems are expected over the life of this opportunity for the Japan NBC Reconnaissance Vehicle. CDS is also under contract to provide technical manuals, training materials, and to conduct training in Japan to allow for in country maintenance of the systems once fielded.

Chemring is a market leading manufacturing business supplying high technology electronics and energetic products to over 80 countries around the world.  Chemring has a diverse portfolio of products that predominantly protect military people and platforms, providing insurance against a constantly changing threat. These range from countermeasures to protect aircraft, to ground penetrating radar to protect troops and vehicles from improvised explosive devices.  Chemring Detection Systems offers various exportable solutions to detect and identify chemical, biological and explosive threats.  CDS is worldwide provider of point detection capability for biological, Chemical Warfare Agents (CWA), Toxic Industrial Chemical (TIC) and explosives trace detection.  Additionally, CDS also provides standoff detection for chemical and explosive threats. 

SOURCE Chemring Detection Systems
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Chemring Detection Systems Awarded $500k for Strategic Research and Development
2. Tests show LLNL detection instrument can monitor the air for all major terrorist threat substances
3. [video] Jacques Tizabi, CEO of Universal Detection Technology Discusses Latest Purchase Order on WallSt.nets 3-Minute Press Show
4. McCain and Obama on Bio-threat Detection and Pandemic Response: QualSec Weighs in
5. Isis Announces Award of Up to $8.4 Million in New Government Grants and Contracts to Its Ibis Biosciences Subsidiary for Pathogen Detection and Human Forensics
6. Waters Publishes Rapid and Specific Method of Detection for Melamine in Infant Formula and Liquid Milk, in Support of Chinas Ministry of Science and Technology
7. Solos Endoscopy, Inc. Applauds American College of Surgeons Review of Advanced Breast Cancer Detection at 94th Annual Clinical Congress
8. International Drug & Explosive Detection Firm Identa Corp Releasing: Jant Pharmacal Corporation Reports Successful Market Penetration of the Accutest(R) IDenta Co-brand in the United States and Oversees
9. BSP Signs Agreement With CMP Trading for Distribution of HyperQ(TM) Stress System, for Early Detection of Ischemic Heart Disease, in South Korea
10. Advances in Detection Technology Drive the European Autoimmune Disease Diagnostics Market
11. New Multi-Center Study Finds Masimo SET Pulse Oximetry Screening Significantly Improves Detection of Congenital Heart Disease in Newborns
Post Your Comments:
(Date:11/25/2015)... , Nov. 25, 2015  PharmAthene, Inc. (NYSE ... has adopted a stockholder rights plan (Rights Plan) in ... operating loss carryforwards (NOLs) under Section 382 of the ... --> PharmAthene,s use of its NOLs could ... change" as defined in Section 382 of the Code. ...
(Date:11/25/2015)... CITY , Nov. 25, 2015 /PRNewswire/ - Aeterna ... affirms that its business and prospects remain fundamentally ... , Zoptrex™ (zoptarelin doxorubicin) recently received DSMB recommendation ... to completion following review of the final interim ... Phase 2 Primary Endpoint in men with heavily ...
(Date:11/24/2015)... Malaysia , Nov. 24, 2015  Asia-Pacific ... contract research organisation (CRO) market. The trend of ... in lower margins but higher volume share for ... capacity and scale, however, margins in the CRO ... Organisation (CRO) Market ( ), finds ...
(Date:11/24/2015)... Mass. (PRWEB) , ... November 24, 2015 , ... ... to maintain healthy metabolism. But unless it is bound to proteins, copper is ... of Health (NIH), researchers at Worcester Polytechnic Institute (WPI) will conduct a systematic ...
Breaking Biology Technology:
(Date:11/17/2015)... Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" and ... of broadly enabling, pressure cycling technology ("PCT")-based sample preparation ... it has received gross proceeds of $745,000 from an ... "Offering"), increasing the total amount raised to date in ... are expected in the near future. ...
(Date:11/12/2015)... , Nov. 12, 2015  Arxspan has entered ... MIT and Harvard for use of its ArxLab ... management tools. The partnership will support the institute,s ... and chemical research information internally and with external ... used for managing the Institute,s electronic laboratory notebook, ...
(Date:11/10/2015)... 10, 2015  In this report, the ... of product, type, application, disease indication, and ... report are consumables, services, software. The type ... biomarkers, efficacy biomarkers, and validation biomarkers. The ... diagnostics development, drug discovery and development, personalized ...
Breaking Biology News(10 mins):